BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 12554609)

  • 1. Primary and secondary substance misusers: do they differ in substance-induced and substance-independent mental disorders?
    Bakken K; Landheim AS; Vaglum P
    Alcohol Alcohol; 2003; 38(1):54-9. PubMed ID: 12554609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbid mental disorders in substance users from a single catchment area--a clinical study.
    Langås AM; Malt UF; Opjordsmoen S
    BMC Psychiatry; 2011 Feb; 11():25. PubMed ID: 21314980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence between personality disorders and substance use disorder. Madrid study about prevalence of dual pathology.
    González E; Arias F; Szerman N; Vega P; Mesias B; Basurte I
    Actas Esp Psiquiatr; 2019 Nov; 47(6):218-28. PubMed ID: 31869422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbid substance and mental disorders among rural Americans: results from the National Comorbidity Survey.
    Simmons LA; Havens JR
    J Affect Disord; 2007 Apr; 99(1-3):265-71. PubMed ID: 16978706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What characterizes substance abusers who commit suicide attempts? Factors related to Axis I disorders and patterns of substance use disorders. A study of treatment-seeking substance abusers in Norway.
    Landheim AS; Bakken K; Vaglum P
    Eur Addict Res; 2006; 12(2):102-8. PubMed ID: 16543746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzodiazepine prescription practices and substance abuse in persons with severe mental illness.
    Clark RE; Xie H; Brunette MF
    J Clin Psychiatry; 2004 Feb; 65(2):151-5. PubMed ID: 15003066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric disorders among drug dependent subjects: are they primary or secondary?
    Compton WM; Cottler LB; Phelps DL; Ben Abdallah A; Spitznagel EL
    Am J Addict; 2000; 9(2):126-34. PubMed ID: 10934574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort.
    Davis LL; Rush JA; Wisniewski SR; Rice K; Cassano P; Jewell ME; Biggs MM; Shores-Wilson K; Balasubramani GK; Husain MM; Quitkin FM; McGrath PJ
    Compr Psychiatry; 2005; 46(2):81-9. PubMed ID: 15723023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of alcohol and drug dependence on the course of depression.
    Agosti V; Levin FR
    Am J Addict; 2006; 15(1):71-5. PubMed ID: 16449095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidity rates do not support distinction between panic disorder and generalized anxiety disorder.
    Starcevic V; Fallon S; Uhlenhuth EH; Pathak D
    Psychopathology; 1994; 27(6):269-72. PubMed ID: 7846249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-morbid post-traumatic stress disorder in a substance misusing clinical population.
    Reynolds M; Mezey G; Chapman M; Wheeler M; Drummond C; Baldacchino A
    Drug Alcohol Depend; 2005 Mar; 77(3):251-8. PubMed ID: 15734225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent versus substance-induced major depressive disorders in first-admission patients with substance use disorders: an exploratory study.
    Langås AM; Malt UF; Opjordsmoen S
    J Affect Disord; 2013 Jan; 144(3):279-83. PubMed ID: 23158758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affective disorder in the parents of a clinic sample of children with anxiety disorders.
    Cooper PJ; Fearn V; Willetts L; Seabrook H; Parkinson M
    J Affect Disord; 2006 Jul; 93(1-3):205-12. PubMed ID: 16675030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-occurrence of obsessive-compulsive disorder and substance use disorder in the general population.
    Blom RM; Koeter M; van den Brink W; de Graaf R; Ten Have M; Denys D
    Addiction; 2011 Dec; 106(12):2178-85. PubMed ID: 21714825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance use disorders among personality disordered patients admitted for day hospital treatment. Implications for service developments.
    Karterud S; Arefjord N; Andresen NE; Pedersen G
    Nord J Psychiatry; 2009; 63(1):57-63. PubMed ID: 19172500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health insurance and treatment of adolescents with co-occurring major depression and substance use disorders.
    Dicola LA; Gaydos LM; Druss BG; Cummings JR
    J Am Acad Child Adolesc Psychiatry; 2013 Sep; 52(9):953-60. PubMed ID: 23972697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use disorders in individuals with body dysmorphic disorder.
    Grant JE; Menard W; Pagano ME; Fay C; Phillips KA
    J Clin Psychiatry; 2005 Mar; 66(3):309-16; quiz 404-5. PubMed ID: 15766296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder.
    Tadić A; Wagner S; Hoch J; Başkaya O; von Cube R; Skaletz C; Lieb K; Dahmen N
    Psychopathology; 2009; 42(4):257-63. PubMed ID: 19521142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance use disorders and comorbid mental disorders in first-time admitted patients from a catchment area.
    Langås AM; Malt UF; Opjordsmoen S
    Eur Addict Res; 2012; 18(1):16-25. PubMed ID: 22042311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 1-month prevalence of generalized anxiety disorder according to DSM-IV, DSM-V, and ICD-10 among nondemented 75-year-olds in Gothenburg, Sweden.
    Nilsson J; Östling S; Waern M; Karlsson B; Sigström R; Guo X; Skoog I
    Am J Geriatr Psychiatry; 2012 Nov; 20(11):963-72. PubMed ID: 22549369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.